Search Results 271-280 of 16553 for ������������KA���:ZA31���24������ ���������������������������������

  1. Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation - Mayo Clinic

    Jacksonville, Florida: 24-000012; Scottsdale/Phoenix, Arizona: 24-000012. NCT ID: NCT06106308. Sponsor Protocol Number: CRDF-004. About this study. The ...

  2. Publications - Vlad C. Vasile, M.D., Ph.D. - Mayo Clinic

    2017 Aug 24; 19 (10):92. View PubMed; Vasile VC, Jaffe AS. Natriuretic Peptides and Analytical Barriers. Clin Chem. 2017 Jan; 63 (1):50-58 Epub 2016 Oct 10

  3. Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in Treatment-Naïve HCV Genotype 1-Infected Adults With Chronic Kidney Disease - Mayo Clinic

    About this study. This open-label study will evaluate safety, pharmacokinetics and efficacy of a 12 or 24 week regimen of ombitasvir/ABT-450/ritonavir and ...

  4. Cancer Treatment! Clinical Trials - Mayo Clinic Research

    ... 24 than treatment with Best Available Therapy, and a greater proportion of patients achieving a ≥ 50% reduction in total symptom score from baseline to ...

  5. SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients - Mayo Clinic

    - To assess the relationship between clinical effects (adverse event [AE] and/or tumor response) and CD38 receptor density at baseline (Part A). Participation ...

  6. Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis - Mayo Clinic

    About this study. The purpose of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm ...

  7. A Study of Cediranib and Olaparib Combined, Compared to Either Drug Alone, or to a Standard Chemotherapy in Treating Patients who have a Return of Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

    Cediranib maleate and olaparib may stop the growth of tumor cells by blocking enzymes needed for cell growth. Drugs used in chemotherapy work in different ways ...

  8. Alternate Doses and Dosing Schedules of Belantamab Mafodotin for the Treatment of Triple-Class Recurrent and/or Refractory Multiple Myeloma - Mayo Clinic

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

  9. Siegel TAVR in Aortic Severe Stenosis - Clinical Trials

    Life expectancy < 24 months due to associated non-cardiac co-morbid conditions; Other medical, social, or psychological conditions that in the opinion of an ...

  10. Publications - Aqsa A. Khan, M.D. - Mayo Clinic

    Lee YS, Khan AA. Financial Toxicity for Female Patients with Urinary Incontinence. Curr Urol Rep. 2023 Jan; 24(1):33-39. Epub 2022 Dec 17.